Certain herbal and complementary medicines may be a valuable treatment option for women with postmenopausal symptoms, according to a new review outlining the advantages and limitations of the available treatments of postmenopausal symptoms.
Today, the FDA approved Oxytrol for Women, a patch containing oxybutynin that treats overactive bladder, for over-the-counter sale to women ages 18 and older.
The available evidence shows that the use of local estrogen treatment may improve the symptoms of urinary incontinence in postmenopausal women but that systemic estrogen worsens incontinence.
Use of surgical mesh to correct vaginal vault prolapse after a hysterectomy is associated with a lower risk of prolapse recurrence at 1 year than sacrospinous fixation (SSF), according to results of a new study
Oral anticholinergic medications and onabotulinumtoxinA (Botox) injections are equally effective for the treatment of urgency urinary incontinence in women, according to new study findings, but have different side effects.
A noninvasive, simple visual examination of the urethral meatus is a useful alternative to the Q-Tip test for detecting urethral hypermobility in women.
In a new systematic review, researchers studied the benefits and harms of pharmacological therapies for overactive bladder in women.
A new study found that placement of a midurethral sling can halve the rate of incontinence after prolapse surgery
The U.S. Preventive Services Task Force has issued draft recommendations for postmenopausal hormone therapy for the primary prevention of chronic conditions, such as heart
disease, stroke, dementia, hip fracture, and breast cancer.
There is an ongoing debate as to whether or not pre-operative urodynamic testing offers any value in uncomplicated stress urinary incontinence patients who are undergoing surgery.